1. Home
  2. ZYXI vs NUKK Comparison

ZYXI vs NUKK Comparison

Compare ZYXI & NUKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZYXI
  • NUKK
  • Stock Information
  • Founded
  • ZYXI 1996
  • NUKK 2013
  • Country
  • ZYXI United States
  • NUKK United States
  • Employees
  • ZYXI N/A
  • NUKK N/A
  • Industry
  • ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NUKK Blank Checks
  • Sector
  • ZYXI Health Care
  • NUKK Finance
  • Exchange
  • ZYXI Nasdaq
  • NUKK Nasdaq
  • Market Cap
  • ZYXI 66.5M
  • NUKK 77.4M
  • IPO Year
  • ZYXI N/A
  • NUKK N/A
  • Fundamental
  • Price
  • ZYXI $2.02
  • NUKK $15.25
  • Analyst Decision
  • ZYXI Buy
  • NUKK
  • Analyst Count
  • ZYXI 3
  • NUKK 0
  • Target Price
  • ZYXI $6.00
  • NUKK N/A
  • AVG Volume (30 Days)
  • ZYXI 176.4K
  • NUKK 243.3K
  • Earning Date
  • ZYXI 07-24-2025
  • NUKK 06-10-2025
  • Dividend Yield
  • ZYXI N/A
  • NUKK N/A
  • EPS Growth
  • ZYXI N/A
  • NUKK N/A
  • EPS
  • ZYXI N/A
  • NUKK N/A
  • Revenue
  • ZYXI $172,401,000.00
  • NUKK N/A
  • Revenue This Year
  • ZYXI N/A
  • NUKK N/A
  • Revenue Next Year
  • ZYXI $19.55
  • NUKK N/A
  • P/E Ratio
  • ZYXI N/A
  • NUKK N/A
  • Revenue Growth
  • ZYXI N/A
  • NUKK N/A
  • 52 Week Low
  • ZYXI $1.66
  • NUKK $1.30
  • 52 Week High
  • ZYXI $10.62
  • NUKK $78.32
  • Technical
  • Relative Strength Index (RSI)
  • ZYXI 40.53
  • NUKK 47.71
  • Support Level
  • ZYXI $2.21
  • NUKK $13.05
  • Resistance Level
  • ZYXI $2.66
  • NUKK $26.21
  • Average True Range (ATR)
  • ZYXI 0.20
  • NUKK 2.51
  • MACD
  • ZYXI 0.02
  • NUKK -0.45
  • Stochastic Oscillator
  • ZYXI 5.19
  • NUKK 16.72

About ZYXI Zynex Inc.

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

About NUKK Nukkleus Inc.

Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).

Share on Social Networks: